London, UK – 5 September 2023 – Engitix Ltd (‘Engitix’), a biotechnology company with a portfolio of drug discovery programmes in fibrosis and solid tumours using its proprietary patient-centric human extracellular matrix (ECM) platform, today announces the appointment of Christopher (Chris) Stevenson, Ph.D. as Chief Scientific Officer (CSO). In this new role, Chris will be responsible […]
London, UK – 5 October 2022 – Engitix Ltd (‘Engitix’), a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix (ECM) platform, today celebrated its expansion and growth with a Grand Opening at its new facilities in White City, West London. Engitix purpose-designed mixed-use headquarters and R&D […]
Engitix is looking for an enthusiastic and proactive Laboratory Support Technician to support scientists and contribute to the smooth running of the laboratory. The role would suit a candidate who is looking to gain experience in a laboratory setting and has interest in science. The role is full time and reports to the Laboratory Manager. […]
